Compound 1854
Identifiers
- Canonical SMILES:
Cc1[nH]c(cc1C(N)=O)-c1cc(NS(C)(=O)=O)ccc1Oc1ccccc1
- IUPAC name:
5-(5-methanesulfonamido-2-phenoxyphenyl)-2-methyl-1H-pyrrole-3-carboxamide
- InChi:
InChI=1S/C19H19N3O4S/c1-12-15(19(20)23)11-17(21-12)16-10-13(22-27(2,24)25)8-9-18(16)26-14-6-4-3-5-7-14/h3-11,21-22H,1-2H3,(H2,20,23)
- InChiKey:
ZZTOGTBTPJGXNS-UHFFFAOYSA-N
External links
![]() 90415492 |
![]() CHEMBL4060309 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.55 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 385.11 g/mol | |||
HBA | 7 | |||
HBD | 4 | |||
HBA + HBD | 11 | |||
AlogP | 1.54 | |||
TPSA | 114.28 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2017.02.057 | 12 | BRD4 O60885 |
H4 P62805 |
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 6.55 | |
10.1016/j.bmcl.2017.02.057 | 12 | BRD4 O60885 |
H4 P62805 |
Cellular assay | MX-1 proliferation assay | MX-1 | pEC50 (half maximal effective concentration, -log10) | 6.00 |
10.1016/j.bmcl.2017.02.057 | 12 | BRD4 O60885 |
H4 P62805 |
Cellular assay | Luciferase reporter | H1299 | pEC50 (half maximal effective concentration, -log10) | 5.85 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4700 | 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DB08358 | |
0.4444 | 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DB07728 | |
0.4438 | 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE | DB08350 | |
0.4383 | [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA | DB07247 | |
0.4337 | 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide | DB04010 | |
0.4246 | Apricoxib | DB12378 | |
0.4231 | Esaxerenone | DB15207 | |
0.4154 | Pavinetant | DB11692 | |
0.4133 | Dasabuvir | DB09183 | |
0.4103 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4085 | 2,3-diphenyl-1H-indole-7-carboxylic acid | DB08709 | |
0.4064 | Losmapimod | DB12270 | |
0.4059 | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide | DB03509 | |
0.4053 | Atorvastatin | DB01076 | |
0.4052 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 |